Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 193

1.

Chromium Exposure and Risk of Cardiovascular Disease in High Cardiovascular Risk Subjects - Nested Case-Control Study in the Prevention With Mediterranean Diet (PREDIMED) Study.

Gutiérrez-Bedmar M, Martínez-González MÁ, Muñoz-Bravo C, Ruiz-Canela M, Mariscal A, Salas-Salvadó J, Estruch R, Corella D, Arós F, Fito M, Lapetra J, Serra-Majem L, Pintó X, Alonso-Gómez Á, Portoles O, Fiol M, Bulló M, Castañer O, Ros E, Gómez-Gracia E.

Circ J. 2017 Apr 8. doi: 10.1253/circj.CJ-17-0032. [Epub ahead of print]

2.

The Mediterranean Diet decreases LDL atherogenicity in high cardiovascular risk individuals: a randomized controlled trial.

Hernáez Á, Castañer O, Goday A, Ros E, Pintó X, Estruch R, Salas-Salvadó J, Corella D, Arós F, Serra-Majem L, Martínez-González MÁ, Fiol M, Lapetra J, de la Torre R, López-Sabater MC, Fitó M.

Mol Nutr Food Res. 2017 Apr 3. doi: 10.1002/mnfr.201601015. [Epub ahead of print]

PMID:
28371298
3.

Prediction of Cardiovascular Disease by the Framingham-REGICOR Equation in the High-Risk PREDIMED Cohort: Impact of the Mediterranean Diet Across Different Risk Strata.

Amor AJ, Serra-Mir M, Martínez-González MA, Corella D, Salas-Salvadó J, Fitó M, Estruch R, Serra-Majem L, Arós F, Babio N, Ros E, Ortega E; PREDIMED Investigators ..

J Am Heart Assoc. 2017 Mar 13;6(3). pii: e004803. doi: 10.1161/JAHA.116.004803.

4.

Dietary energy density and body weight changes after 3 years in the PREDIMED study.

Razquin C, Sanchez-Tainta A, Salas-Salvadó J, Buil-Cosiales P, Corella D, Fito M, Ros E, Estruch R, Arós F, Gómez-Gracia E, Fiol M, Lapetra J, Serra-Majem L, Pinto X, Schröder H, Tur J, Sorlí JV, Lamuela-Raventós RM, Bulló M, Bes-Rastrollo M, Martinez-Gonzalez MA; PREDIMED GROUP..

Int J Food Sci Nutr. 2017 Mar 6:1-8. doi: 10.1080/09637486.2017.1295028. [Epub ahead of print]

PMID:
28276290
5.

Leisure-time physical activity, sedentary behaviors, sleep, and cardiometabolic risk factors at baseline in the PREDIMED-PLUS intervention trial: A cross-sectional analysis.

Rosique-Esteban N, Díaz-López A, Martínez-González MA, Corella D, Goday A, Martínez JA, Romaguera D, Vioque J, Arós F, Garcia-Rios A, Tinahones F, Estruch R, Fernández-García JC, Lapetra J, Serra-Majem L, Pinto X, Tur JA, Bueno-Cavanillas A, Vidal J, Delgado-Rodríguez M, Daimiel L, Vázquez C, Rubio MÁ, Ros E, Salas-Salvadó J; PREDIMED-PLUS investigators..

PLoS One. 2017 Mar 8;12(3):e0172253. doi: 10.1371/journal.pone.0172253. eCollection 2017.

6.

Omega-3 fatty acids as adjunctive treatment for bexarotene-induced hypertriglyceridaemia in patients with cutaneous T-cell lymphoma.

Cabello I, Servitje O, Corbella X, Bardés I, Pintó X.

Clin Exp Dermatol. 2017 Apr;42(3):276-281. doi: 10.1111/ced.13044. Epub 2017 Feb 24.

PMID:
28233333
7.

Mediterranean Diet Improves High-Density Lipoprotein Function in High-Cardiovascular-Risk Individuals: A Randomized Controlled Trial.

Hernáez Á, Castañer O, Elosua R, Pintó X, Estruch R, Salas-Salvadó J, Corella D, Arós F, Serra-Majem L, Fiol M, Ortega-Calvo M, Ros E, Martínez-González MÁ, de la Torre R, López-Sabater MC, Fitó M.

Circulation. 2017 Feb 14;135(7):633-643. doi: 10.1161/CIRCULATIONAHA.116.023712.

PMID:
28193797
8.

Consensus document on the management of the atherogenic dyslipidaemia of the Spanish Society of Arteriosclerosis.

Ascaso JF, Millán J, Hernández-Mijares A, Blasco M, Brea Á, Díaz Á, Mantilla T, Pedro-Botet J, Pintó X; Grupo de trabajo sobre Dislipemia Aterogénica de la SEA..

Clin Investig Arterioscler. 2017 Mar - Apr;29(2):86-91. doi: 10.1016/j.arteri.2016.11.001. Epub 2017 Feb 6. English, Spanish.

PMID:
28185675
9.

Mediterranean diet and risk of heart failure: results from the PREDIMED randomized controlled trial.

Papadaki A, Martínez-González MÁ, Alonso-Gómez A, Rekondo J, Salas-Salvadó J, Corella D, Ros E, Fitó M, Estruch R, Lapetra J, García-Rodriguez A, Fiol M, Serra-Majem L, Pintó X, Ruiz-Canela M, Bulló M, Serra-Mir M, Sorlí JV, Arós F.

Eur J Heart Fail. 2017 Jan 30. doi: 10.1002/ejhf.750. [Epub ahead of print]

PMID:
28133855
10.

Changes in fatty liver index after consuming a Mediterranean diet: 6-year follow-up of the PREDIMED-Malaga trial.

Cueto-Galán R, Barón FJ, Valdivielso P, Pintó X, Corbella E, Gómez-Gracia E, Wärnberg J; los investigadores del Estudio PREDIMED..

Med Clin (Barc). 2017 Jan 23. pii: S0025-7753(16)30680-7. doi: 10.1016/j.medcli.2016.11.032. [Epub ahead of print] English, Spanish.

PMID:
28126231
11.

Associations between Both Lignan and Yogurt Consumption and Cardiovascular Risk Parameters in an Elderly Population: Observations from a Cross-Sectional Approach in the PREDIMED Study.

Creus-Cuadros A, Tresserra-Rimbau A, Quifer-Rada P, Martínez-González MA, Corella D, Salas-Salvadó J, Fitó M, Estruch R, Gómez-Gracia E, Lapetra J, Arós F, Fiol M, Ros E, Serra-Majem L, Pintó X, Moreno JJ, Ruiz-Canela M, Sorli JV, Basora J, Schröder H, Lamuela-Raventós RM; PREDIMED Study Investigators..

J Acad Nutr Diet. 2017 Apr;117(4):609-622.e1. doi: 10.1016/j.jand.2016.11.003. Epub 2016 Dec 29.

PMID:
28041856
12.

Attainment of LDL Cholesterol Treatment Goals in Children and Adolescents With Familial Hypercholesterolemia. The SAFEHEART Follow-up Registry.

Saltijeral A, Pérez de Isla L, Alonso R, Muñiz O, Díaz-Díaz JL, Fuentes F, Mata N, de Andrés R, Díaz-Soto G, Pastor J, Pinilla JM, Zambón D, Pinto X, Badimón L, Mata P; SAFEHEART Investigators..

Rev Esp Cardiol (Engl Ed). 2016 Nov 29. pii: S1885-5857(16)30330-9. doi: 10.1016/j.rec.2016.10.010. [Epub ahead of print] English, Spanish.

PMID:
27913073
13.

[Anti-PCSK9 antibodies in type 2 diabetes and secondary prevention of cardiovascular diseases].

López-Miranda J, Pintó X.

Clin Investig Arterioscler. 2016 May;28 Suppl 2:31-38. doi: 10.1016/S0214-9168(16)30168-1. Spanish.

PMID:
27888904
14.

[Chronic kidney disease and dyslipidaemia].

Pascual V, Serrano A, Pedro-Botet J, Ascaso J, Barrios V, Millán J, Pintó X, Cases A.

Clin Investig Arterioscler. 2017 Jan - Feb;29(1):22-35. doi: 10.1016/j.arteri.2016.07.004. Epub 2016 Nov 15. Spanish.

PMID:
27863896
15.

[Nonalcoholic fatty liver disease, association with cardiovascular disease snd treatment. (I). Nonalcoholic fatty liver disease and its association with cardiovascular disease].

Brea Á, Pintó X, Ascaso JF, Blasco M, Díaz Á, González-Santos P, Hernández Mijares A, Mantilla T, Millán J, Pedro-Botet J; Grupo de trabajo sobre Dislipemia Aterogénica. Sociedad Española de Arteriosclerosis..

Clin Investig Arterioscler. 2016 Sep 27. pii: S0214-9168(16)30076-6. doi: 10.1016/j.arteri.2016.06.003. [Epub ahead of print] Spanish.

PMID:
27692633
16.

[Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment (II). The treatment of nonalcoholic fatty liver disease].

Brea Á, Pintó X, Ascaso JF, Blasco M, Díaz Á, González-Santos P, Hernández-Mijares A, Mantilla T, Millán J, Pedro-Botet J; Grupo de trabajo sobre Dislipemia Aterogénica, Sociedad Española de Arteriosclerosis..

Clin Investig Arterioscler. 2016 Sep 27. pii: S0214-9168(16)30075-4. doi: 10.1016/j.arteri.2016.06.002. [Epub ahead of print] Spanish.

PMID:
27692632
17.

[The real measurement of non-HDL-cholesterol: Atherogenic cholesterol].

Millán J, Hernández-Mijares A, Ascaso JF, Blasco M, Brea A, Díaz Á, González-Santos P, Mantilla T, Pedro-Botet J, Pintó X; Grupo de trabajo sobre Dislipemia Aterogénica. Sociedad Española de Arteriosclerosis..

Clin Investig Arterioscler. 2016 Nov - Dec;28(6):265-270. doi: 10.1016/j.arteri.2016.05.002. Epub 2016 Sep 12. Spanish.

PMID:
27633523
18.

[Fibrates therapy: Rational use fenofibrate 2016. Executive summary].

Brea A, Millán J, Ascaso JF, Blasco M, Díaz A, González-Santos P, Hernández-Mijares A, Mantilla T, Pedro-Botet JC, Pintó X; en nombre del Foro de la Dislipemia Aterogénica..

Clin Investig Arterioscler. 2016 Nov - Dec;28(6):295-301. doi: 10.1016/j.arteri.2016.06.001. Epub 2016 Sep 5. Spanish.

PMID:
27609708
19.

Clinical and molecular characteristics of homozygous familial hypercholesterolemia patients: Insights from SAFEHEART registry.

Alonso R, Díaz-Díaz JL, Arrieta F, Fuentes-Jiménez F, de Andrés R, Saenz P, Ariceta G, Vidal-Pardo JI, Almagro F, Argueso R, Prieto-Matos P, Miramontes JP, Pintó X, Rodriguez-Urrego J, Perez de Isla L, Mata P.

J Clin Lipidol. 2016 Jul-Aug;10(4):953-61. doi: 10.1016/j.jacl.2016.04.006. Epub 2016 Apr 21.

PMID:
27578128
20.

Dietary Marine ω-3 Fatty Acids and Incident Sight-Threatening Retinopathy in Middle-Aged and Older Individuals With Type 2 Diabetes: Prospective Investigation From the PREDIMED Trial.

Sala-Vila A, Díaz-López A, Valls-Pedret C, Cofán M, García-Layana A, Lamuela-Raventós RM, Castañer O, Zanon-Moreno V, Martinez-Gonzalez MA, Toledo E, Basora J, Salas-Salvadó J, Corella D, Gómez-Gracia E, Fiol M, Estruch R, Lapetra J, Fitó M, Arós F, Serra-Majem L, Pintó X, Ros E; Prevención con Dieta Mediterránea (PREDIMED) Investigators..

JAMA Ophthalmol. 2016 Oct 1;134(10):1142-1149. doi: 10.1001/jamaophthalmol.2016.2906.

PMID:
27541690

Supplemental Content

Loading ...
Support Center